Effects of Diet and Gemfibrozil on Posttransplant Hyperlipidemia in Renal Transplant Recipients

sapan, Muzaffer; ÖZBEN SADIÇ, BESTE; yakupoğlu, Gulsen; SÜLEYMANLAR, GÜLTEKİN; Ozben, TOMRİS

doi:10.2310/jim.0b013e318197da68

Effects of Diet and Gemfibrozil on Posttransplant Hyperlipidemia in Renal Transplant Recipients

sapan M., ÖZBEN SADIÇ B., yakupoğlu G., SÜLEYMANLAR G., Ozben T.

JOURNAL OF INVESTIGATIVE MEDICINE, vol.57, no.2, pp.456-459, 2009 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 57 Issue: 2
Publication Date: 2009
Doi Number: 10.2310/jim.0b013e318197da68
Journal Name: JOURNAL OF INVESTIGATIVE MEDICINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.456-459
Keywords: Gemfibrozil, hyperlipidemia, renal transplantation, American phase 3 diet, DENSITY-LIPOPROTEIN CHOLESTEROL, CORONARY-ARTERY-DISEASE, RANDOMIZED CONTROLLED-TRIAL, SECONDARY PREVENTION, OXIDATIVE STRESS, KIDNEY-TRANSPLANTATION, CARDIOVASCULAR-DISEASE, MYOCARDIAL-INFARCTION, DIABETES-MELLITUS, HDL CHOLESTEROL
Akdeniz University Affiliated: Yes

Abstract

Background: Posttransplant hyperlipidemia increases cardiovascular morbidity and mortality rate in renal transplant recipients. It also leads, to graft loss due to atherosclerosis and glomerular damage. It is essential to control hyperlipidemia in renal transplant recipients to prevent these events.